Amyris Biotechnologies - Top 20 Biotech VC Deals of 2009

Company: Amyris Biotechnologies
Based: Emeryville, CA
Amount: $41.75 million

Investors: Grupo Cornelio Brennand, Naxos, Khosla Ventures, Kleiner Perkins Caufield & Byers, TPG Biotech and Votorantim Novos Negocios

Scoop: Amyris Biotechnologies, which also produces biofeuls and other chemicals, raised $41.75 million as part of a C round to fund the commercialization of its products in 2011, according to Greentechmedia. Amyris was able to raise the first, $24.7 million by August, according to its filing with the SEC. The filing says the company was seeking to raise $62 million.

Under a non-profit initiative, Amyris has applied its technology to provide a second source of artemisinin, an anti-malarial therapy, which will be commercialized by Sanofi-Aventis. 

Related Article:
Amyris Biotechnologies - Top 20 VC deals of 2008